 |
Rubius Therapeutics
Last updated: September 30, 2025
Torben Straight Nissen, CEO
USA | Funding: $445M (+)
Website: https://www.rubiustx.com/
Rubius is developing a new class of drugs, Red-Cell Therapeutics. Rubius is using advanced cellular therapies that harness the unique, inherent properties of red cells and marry them to the creative power of genetic engineering.
Website: https://www.rubiustx.com/
Rubius is developing a new class of drugs, Red-Cell Therapeutics. Rubius is using advanced cellular therapies that harness the unique, inherent properties of red cells and marry them to the creative power of genetic engineering.
